MeiraGTx Holdings (MGTX) Tax Provisions (2018 - 2026)
MeiraGTx Holdings' (MGTX) quarterly Tax Provisions came in at $3.5 million in Q4 2019, up 837.59% YoY from $373197.3 in Q4 2018, and up 1133.18% on a QoQ basis from -$338670.0 in Q3 2019.
Powered by 
Analysis
MeiraGTx Holdings (MGTX) Tax Provisions (2018 - 2026) Analysis & Trends
MeiraGTx Holdings (MGTX) has 2 years of Tax Provisions data on file, last reported at $3.5 million in Q4 2019.
- Quarterly Tax Provisions rose 837.59% year-over-year to $3.5 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $2.6 million (changed N/A YoY) and the FY2019 annual result came in at $3.1 million, up 746.93% from the prior year.
- Tax Provisions advanced to $3.5 million in Q4 2019, from -$338670.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $3.5 million in Q4 2019 to a low of -$474391.0 in Q4 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 1.90 Mn |
| 10 | MeiraGTx Holdings | 1.26 Bn | 1.12 Bn | 315.67 Mn | 2.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.36 Mn |
| Dec 31, 2019 | -9.97 Mn |
| Sep 30, 2019 | -338,670.00 |
| Jun 30, 2019 | -91,390.00 |
| Dec 31, 2018 | -474,391.00 |